Oxford Biomedica
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners.
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners.
Your career starts on Magnet.me
Create a profile and receive connection requests from interested companies.
Jobs
Interesting to know
This company page was generated automatically and therefore features only limited information. Find out more about Oxford Biomedica on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about Oxford Biomedica on their company website:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.